Lgt Financial Advisors LLC Neurocrine Biosciences Inc Transaction History
Lgt Financial Advisors LLC
- $45.2 Billion
- Q4 2024
A detailed history of Lgt Financial Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 165 shares of NBIX stock, worth $15,656. This represents 0.05% of its overall portfolio holdings.
Number of Shares
165
Previous 165
-0.0%
Holding current value
$15,656
Previous $19 Million
18.47%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
95.9MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.35 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$960 Million0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$464 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$286 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$241 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $9.08B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...